← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Promentis Pharmaceuticals, Inc.
Milwaukee, WI
$2,459,735
Total funding
3
Grants
Funding over time
peak $600K · FY2008–15$1M$750K$500K$250K$0
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$2,459,735 · 3
By mechanism
R44$1,800,000 · 1
R43$659,735 · 2
Investigators at Promentis Pharmaceuticals, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Targeting System Xc- for the Treatment of Schizophrenia$600,000
R44 · FY2012 · MH
Targeting System Xc- for the Treatment of Schizophrenia$600,000
R44 · FY2014 · MH
Targeting System Xc- for the Treatment of Schizophrenia$600,000
R44 · FY2013 · MH
Development of Compounds Targeting xc- for the Treatment of Schizophrenia$257,880
R43 · FY2008 · MH
Development of Compounds Targeting xc- for the Treatment of Schizophrenia$250,489
R43 · FY2009 · MH
Targeting System Xc- for the treatment of the Autism Spectrum Disorder subpopulations, Fragile X syndrome and Phelan-McDermid syndrome$151,366
R43 · FY2015 · HD